Reuters logo
4 months ago
BRIEF-Sunesis Pharmaceuticals provides update on EU marketing app for vosaroxin
March 22, 2017 / 11:27 AM / 4 months ago

BRIEF-Sunesis Pharmaceuticals provides update on EU marketing app for vosaroxin

1 Min Read

March 22 (Reuters) - Sunesis Pharmaceuticals Inc

* Sunesis pharmaceuticals announces submission of responses to ema day 180 list of outstanding issues for marketing authorization application for vosaroxin

* Sunesis pharmaceuticals inc - "anticipating a chmp decision by mid-year"

* Sunesis pharmaceuticals - continue to work to qualify "best pharma partner" to work with us on european market launch of vosaroxin in h2 of 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below